# Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

> **NCT00237523** · PHASE3 · UNKNOWN · sponsor: **Symbollon Pharmaceuticals** · enrollment: 175 (estimated)

## Conditions studied

- Fibrocystic Disease of Breast
- Fibrocystic Changes of Breast
- Fibrocystic Mastopathy
- Pain

## Interventions

- **DRUG:** IoGen (molecular iodine)

## Key facts

- **NCT ID:** NCT00237523
- **Lead sponsor:** Symbollon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2007-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237523, "Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00237523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*